A Bulgaria Pharmaceuticals and Healthcare Report for Q4 2008: Examine the Effect of Current Reforms, Industry Developments and Detailed Forecasts.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/013ae1/bulgaria_pharmaceu) has announced the addition of the "Bulgaria Pharmaceuticals and Healthcare Report Q4 2008" report to their offering. Bulgaria Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Bulgaria's pharmaceuticals and healthcare industry. EU accession continues to drive forward the drug market in Bulgaria, while an improved business environment means the country is still a relatively attractive prospect for pharmaceutical companies. While the generics market remains backed by the government reimbursement Reimbursement Payment made to someone for out-of-pocket expenses has incurred. scheme, innovative firms should see a brighter future in the medium to long term as the intellectual property environment and financial backing for more expensive drugs become apparent. In June the country's Supreme Administrative Court A Supreme Administrative Court is the highest court in a country with jurisdiction over the official decisions of the government. For a specific country, see:
SAC - 1. An early system on the Datatron 200 series. [Listed in CACM 2(5):16 (May 1959)]. ) decided that the way which pharmaceutical prices in the country were determined was contravening a number of regulations, including rules and order of regulation and registration of medicines, the healthcare law, the law on medicines and the national framework contract for 2006. The ruling related to restrictive margins being enforced on wholesalers and as such any future increases would be of benefit to wholesalers rather than manufacturers. The World Bank has recently criticised Bulgaria's efforts to reform its healthcare system as chaotic. The government is currently attempting to privatise Verb 1. privatise - change from governmental to private control or ownership; "The oil industry was privatized" privatize manufacture, industry - the organized action of making of goods and services for sale; "American industry is making increased use of the health insurance sector, however, its unrealistically short time-scale and stalls in privatising hospitals make successful reforms look unlikely at present. However, a more positive development is the news that the government plans to spend 50% of its budget surplus on social benefits, education and improving the healthcare sector. The budget surplus increased to BGN BGN In currencies, this is the abbreviation for the Bulgarian Lev. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 4.2bn (US$3.12bn) in the first seven months of 2008 from BGN2.4bn a year ago. Meanwhile in response to the government's delays, construction of private medical facilities has been rife rife adj. rif·er, rif·est 1. In widespread existence, practice, or use; increasingly prevalent. 2. Abundant or numerous. , with investors seeking to capitalise on the population's rising personal income and increasing health awareness. Growing private healthcare expenditure should be one of the key drivers behind medical device sales in the country, for which we have added our five year forecast this quarter. Enforced compliance with EU good manufacturing practice Good Manufacturing Practice or GMP (also referred to as 'cGMP' or 'current Good Manufacturing Practice') is a term that is recognized worldwide for the control and management of manufacturing and quality control testing of foods and pharmaceutical products. (GMP GMP (guanosine monophosphate): see guanine. ) regulations should further drive imports of higher value devices, with the market forecasted to reach nearly US$260mn by 2012, out-growing the pharmaceutical sector. Key Topics Covered: - Bulgaria Pharmaceuticals And Healthcare SWOT - Bulgaria - Market Summary - Regulatory Regime - Industry Developments - Healthcare Sector - Industry Forecast Scenario - Overall Market Forecast - Key Growth Factors - Industry - Macroeconomic mac·ro·ec·o·nom·ics n. (used with a sing. verb) The study of the overall aspects and workings of a national economy, such as income, output, and the interrelationship among diverse economic sectors. Forecast Scenario - Prescription Market Forecast - Patented Market Forecast - Generics Market Forecast - OTC Market Noun 1. OTC market - a stock exchange where securities transactions are made via telephone and computer rather than on the floor of an exchange over-the-counter market Forecast - Export/Import Market Forecasts - Medical Device Forecast - Other Healthcare Data Forecasts - Key Risks To BMI's Forecast Scenario - Competitive Landscape - Research And Development - Clinical Trials - Company Monitor Companies Mentioned: - GlaxoSmithKline - Novartis - Sanofi-Aventis - Pfizer - Merck & Co - Actavis Bulgaria (formerly Balkanpharma) - Sopharma - Biovet For more information visit http://www.researchandmarkets.com/research/013ae1/bulgaria_pharmaceu |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion